JSM2024
Back to all people

Gregory Chen

Merck & Co., Inc.
1 appearance in the program

Sessions & presentations

Statistical Innovation in Oncology Drug Development
Presentation: Impact of informative censoring in randomized trials with delayed treatment effect
Contributed Papers · Wed, Aug 7 , 10:30 AM
Co-Author